Vaccination utilizing the FimCH complex as a strategy to prevent Escherichia coli urinary tract infections.
Langermann
S
S
MedImmune, Inc., 35 W. Watkins Mill Rd., Gaithersburg, MD 20878, USA. langermanns@medimmune.com
Ballou
W R
WR
D018829:Adhesins, Bacterial; D018830:Adhesins, Escherichia coli; D001425:Bacterial Outer Membrane Proteins; D001426:Bacterial Proteins; D004926:Escherichia coli / Q000737:chemistry / Q000276:immunology*; D004927:Escherichia coli Infections / Q000517:prevention & control*; D029968:Escherichia coli Proteins; D022361:Escherichia coli Vaccines / Q000008:administration & dosage*; D036781:Fimbriae Proteins; D006801:Humans; D014552:Urinary Tract Infections / Q000382:microbiology / Q000517:prevention & control*; D014611:Vaccination
D018829:Adhesins, Bacterial; D018830:Adhesins, Escherichia coli; D001425:Bacterial Outer Membrane Proteins; D001426:Bacterial Proteins; D029968:Escherichia coli Proteins; D022361:Escherichia coli Vaccines; C489721:fimC protein, E coli; C058769:fimH protein, E coli; D036781:Fimbriae Proteins